Evaluation of antileishmanial activity and cytotoxicity of the extracts of Berberis Vulgaris and Nigella sativa against Leishmania tropica

Journal of Vector Borne Diseases

Volumn 51, Issue 4, 2014, Pages 294-299

  Mahmoudvand, Hossein ^a   Sharififar, Fariba ^b   Rahmat, Monireh Sezavar ^b   Tavakoli, Razieh ^b   Dezaki, Ebrahim Saedi ^b   Jahanbakhsh, Sareh ^b   Sharifi, Iraj ^c  

^a LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Department of Pharmacognosy ^*  (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Amastigote; Berberis vulgaris; Black seed; European barberry; Nigella sativa; Promastigote

Indexed keywords

ALCOHOL; ANTILEISHMANIAL AGENT; BERBERIS VULGARIS EXTRACT; CHLOROFORM; MEGLUMINE ANTIMONATE; NIGELLA SATIVA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG; ANTIPROTOZOAL AGENT; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE;

AMASTIGOTE; ANIMAL CELL; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BERBERIS VULGARIS; CONTROLLED STUDY; DRUG CYTOTOXICITY; FRUIT; GROWTH INHIBITION; IC50; IN VITRO STUDY; LEISHMANIA TROPICA; MACROPHAGE; MALE; MOUSE; NONHUMAN; PARASITE VIABILITY; PLANT SEED; PROMASTIGOTE; ANIMAL; BAGG ALBINO MOUSE; BERBERIS; BLACK CUMIN; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; COLORIMETRY; DRUG EFFECTS; ISOLATION AND PURIFICATION; METABOLISM; STAINING; SURVIVAL;

ANIMALS; ANTIPROTOZOAL AGENTS; BERBERIS; CELL SURVIVAL; CELLS, CULTURED; COLORIMETRY; INHIBITORY CONCENTRATION 50; LEISHMANIA TROPICA; MACROPHAGES; MALE; MICE, INBRED BALB C; NIGELLA SATIVA; PLANT EXTRACTS; STAINING AND LABELING; SURVIVAL ANALYSIS; TETRAZOLIUM SALTS; THIAZOLES;

EID: 84919717778     PISSN: 09729062     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Control of the leishmaniasis. Geneva: World Health Organization (WHO Tech Rep Ser 949) 2010; p. 5-12.
2. Desjeux P. Leishmaniasis: Current situation and new perspectives. Comp Immunol Microbiol Infect Dis 2004; 27: 305-18.
3. Sharifi F, Sharifi I, Zarean M, Parizi MH, Aflatoonian M, Harandi MF, et al. Spatial distribution and molecular identification of Leishmania species from endemic foci of southeastern Iran. Iran J Parasitol 2012; 7(1): 45-52.
4. Croft SL, Sundar S, Fairlamb AH. Drug resistance in leishma-niasis. Clin Microbiol Rev 2006; 19(1): 11-26.
5. Jha TK. Drug unresponsiveness and combination therapy for kala-azar. Indian J Med Res 2006; 123(3): 389-98.
6. Pour R, Sharifi I, Kazemi B, Zarean M. Identification of non-responsive isolates to glucantime in patients with cutaneous leish-maniasis in Bam. J Kerman Univ Med Sci 2011; 18(2): 123-33.
7. Santos DO, Coutinho CE, Madeira MF, Bottino CG, Vieira RT, Nascimento SB, et al. Leishmaniasis treatment -A challenge that remains: A review. Parasitol Res 2004; 103: 1-10.
8. Mahmoudvand H, Sharifi1 I, Fasihi Harandi M, Shokohi M, Shakibaie M, Rezaei Rabani T, et al. Antileishmania effects of methotrexate (MTX) alone and in combination with meglumine antimoniate (MA) against Iranian isolate of sensitive and MA-resistant Leishmania tropica: An in-vitro assay. Asian Pacific J Trop Med 2014; 8: 412-20.
9. Rocha LG, Almeida JR, Macedo RO, Barbosa-Filho JM. A review of natural products with antileishmanial activity. Phytomedicine 2005; 12: 514-35.
10. Imanshahidi H, Hosseinzadeh H. Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, Ber-berine. Phytother Res 2008; 22: 999-1012.
11. Kaneda Y, Torii M, Tanaka T, Aikawa M. In vitro effects of berberine sulphate on the growth and structure of Entamoeba histolytica, Giardia lamblia and Trichomonas vaginalis. Ann Trop Med Parasitol 1991; 85: 417-25.
12. Vennerstrom JL, Lovelace JK, Waits VB, Hanson WL, Klayman DL. Berberine derivatives as antileishmanial drugs. Antimicrob Agents Chemother 2005; 34(5): 198-211.
13. Ali B, Blunden G. Pharmacological and toxicological properties of Nigella sativa. Phytother Res 2009; 17: 299-305.
14. Agrawal R, Kharya MD, Shrivastava R. Antimicrobial and an-thelminthic activities of the essential oil of Nigella sativa Linn. Indian J Exp Biol 1979; 17: 1264-5.
15. Mahmoud MR, El-Abhar HS, Saleh S. The effects of Nigella sativa oil against the liver damage induced by Schistosoma mansoni in mice. J Ethnopharmacol 2002; 79: 1-11.
16. Carrio MC, Reiva C, Gallego M, Arboix M, Portus M. Leishma-nia infantum: Stage specific activity of pentavalent antimony related with the assay conditions. Exp Parasitol 2000; 95: 209-14.
17. Lira R, Sundar S, Makharia A, Kenney R, Gam A, Saraiva E, et al. Evidence that the high incidence of treatment failure in Indian Kala azar is due to the emergence of antimony resistant strains of Leishmania donovani. J Infect Dis 1999; 180(2): 564-7.
18. Mahmoudvand H, Sharififar F, Sharifi I, Ezatpour B, Fasihi Harandi M, Makki MS, et al. In vitro inhibitory effect of Berb-eris vulgaris (Berberidaceae) and its main component, Berberine against different Leishmania species. Iranian J Parasitol 2014; 9(1): 28-36.
19. Hay AE, Merza J, Landreau A, Litaudon M, Pagniez F, Le Pape P, et al. Antileishmanial polyphenols from Garcinia vieillardii. Fitoterapia 2008; 79(1): 42-6.
20. Sidan J, Neeradi D, Choudhary A, Singh B, Foley WJ, Singh IP. Antileishmanial polyphenols from Corymbia maculate. J Chem Sci 2013; 125(4): 765-75.
21. Sheng WD, Jiddawi MS, Hong XQ, Abdulla SM. Treatment of chloroquine-resistant malaria using pyrimethamine in combination with berberine, tetracycline or cotrimoxazole. East Afr Med J 1997; 74: 283-4.
22. Fata A, Rakhshandeh H, Berenji F, Jalalifard A. Treatment of cutaneous leishmaniasis in murine model by alcoholic extract of Berberis vulgaris. Iranian J Parasitol 2006; 1(1): 39-42.
23. Kazemi E, Talari S, Hooshyar H. The effect of an alcoholic extract of Berberis vulgaris on cutaneous leishmaniasis (L. major) in Balb/c mice. J School Public Health Inst Pub Health 2007; 5(3): 35-42.
24. Rouhani S, Salehi N, Kamalinejad M, Zoyeri F. Efficacy of Ber-beris vulgaris aqueous extract on viability of Echinococcus granulosus protoscolices. J Invest Surg 2013; 26(6): 347-51.
25. Aljabre SH, Randhawa MA, Akhtar N, Alakloby OM, Alqurashi AM, Aldossary A. Antidermatophyte activity of ether extract of Nigella sativa and its active principle, thymoquinone. J Ethnopharmacol 2005; 101: 116-9.
26. Nilforoushzadeh MA, Hejazi SH, Zarkoob H, Shirani-Bidabadi L, Jaffary L. Efficacy of adding topical honey-based hydro-alcoholic extract Nigella sativa 60% compared to honey alone in patients with cutaneous leishmaniasis receiving intralesional glucantime. J Skin Leishmaniasis 2010; 1: 26-31.
27. Khan A, Khan MS, Avais M, Ijaz M, Ali MM, Abbas T. Prevalence, hematology, and treatment of balantidiasis among donkeys in and around Lahore, Pakistan. Vet Parasitol 2013; 196 (1-2): 203-5.
28. Nasir A, Avais M, Khan MS, Khan JA, Hameed S, Reichel MP. Treating Cryptosporidium parvum infection in calves. J Parasitol 2013; 99(4): 715-7.
29. Randhawa MA, Al-Ghamdi MS. A review of the pharmacothera-peutic effects of Nigella sativa. Pakistan J Med Res 2002; 41: 77-83.
30. Peychev L. Pharmacological investigation on the cardiovascular effects of Berberis vulgaris on tested animals. Pharmacia 2005; 52: 118-21.
31. Badary OA, Al-Shabanah OA, Nagi MN, Al-Bekairi AM, Almazar MA. Acute and subchronic toxicity of thymoquinone in mice. Drug Develop Res 1998; 44: 56-61.
32. Salem ML, Hossain MS. Protective effect of black seed oil from Nigella sativa against murine cytomegalo virus infection. Int J Immunopharmacol 2000; 22: 729-40.